I am very reflective on lessons that I have learned and issues that I have taken up.

It is important for the industry to have up to date information on changes in the market so that they can adapt quickly and make informed business decisions.

I represent probably 25 or 30 marine research entities, both public and private, around Monterey Bay.

the fear also was unintended consequences. This rule would prohibit the research that could be done on building organs and things like that.

Every year this committee talks about the Department doing sunscreen labeling, and nothing gets done.

I think it is going to create tremendous confusion and lose confidence of the consumer.

It appears to be abated?

I hope, with the craziness going on in American politics right now, that you will bring the mental health drugs up to the priority because this country needs a lot of them right now, including Congress.

I am not dead yet.

I think this is something where we have all, including industry and Secretary Vilsack, ought to be taking the lead in this.

We will continue to work on this problem until we have been able to solve what is happening.

Didn't you stop certain manufacturers from importing these treats?

Thank you very much, Mr. Chairman. I also share that line of questioning on generic labeling.

I think that unfortunately, despite what the Chairman says, I think we give you awfully short shrift.

This is my last year in Congress and on this committee, and this is one of the areas I think when I came to Congress I knew very little about the FDA.

The relationship between PHMSA and the industry is too cozy, much like the California Public Utilities Commission has too cozy a relationship with the utilities in California.

I cannot go back to them and face them eye to eye and say that things are any better on the Federal level.

Curbing bad corporate behavior is not a priority.